BioCentury
ARTICLE | Clinical News

Benzoporphyrin derivative: With partner Ciba Vision Ophthalmics, began a Phase I trial in 20 patients to demonstrate safety and proof of concept

May 8, 1995 7:00 AM UTC

Quadra Logic Technologies Inc. (QLTIF), Vancouver Product: Benzoporphyrin derivative, activated by light Indication: Age-related macular degeneration Status: With partner Ciba Vision Ophthalmics, bega...